In a filing, Opus Genetics Inc revealed its Director Gallagher Cam acquired Company’s shares for reported $0.16 million on Dec 29 ’25. In the deal valued at $1.97 per share,83,000 shares were bought. As a result of this transaction, Gallagher Cam now holds 83,000 shares worth roughly $0.18 million.
Then, Gallagher Cam bought 81,000 shares, generating $160,275 in total proceeds. Upon buying the shares at $1.98, the Director now owns 1,891,430 shares.
Before that, Foundation Fighting Blindness sold 4,000,000 shares. Opus Genetics Inc shares valued at $8,600,000 were divested by the Director at a price of $2.15 per share. As a result of the transaction, Foundation Fighting Blindness now holds 5,492,171 shares, worth roughly $11.64 million.
B. Riley Securities initiated its Opus Genetics Inc [IRD] rating to a Buy in a research note published on December 10, 2025; the price target was $9. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in late November with a ‘”an Overweight”‘ rating. Wedbush began covering IRD with “an Outperform” recommendation on October 29, 2025. Chardan Capital Markets started covering the stock on October 16, 2025. It rated IRD as “a Buy”.
Price Performance Review of IRD
On Friday, Opus Genetics Inc [NASDAQ:IRD] saw its stock jump 5.47% to $2.12. Over the last five days, the stock has gained 3.92%. Opus Genetics Inc shares have risen nearly 89.29% since the year began. Nevertheless, the stocks have risen 5.47% over the past one year. While a 52-week high of $2.59 was reached on 01/02/26, a 52-week low of $0.65 was recorded on 01/02/26.
Levels Of Support And Resistance For IRD Stock
The 24-hour chart illustrates a support level at 2.00, which if violated will result in even more drops to 1.87. On the upside, there is a resistance level at 2.29. A further resistance level may holdings at 2.45.
How much short interest is there in Opus Genetics Inc?
A steep rise in short interest was recorded in Opus Genetics Inc stocks on 2025-12-15, growing by 0.25 million shares to a total of 0.64 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 0.39 million shares. There was a rise of 39.24%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 11, 2025 when Craig Hallum began covering the stock and recommended ‘”a Buy”‘ rating along with a $6 price target.
